In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 16th, 2008 | 21 | Yes |
Popular Name: Triprolidine hydrochloride Triprolidine hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 486-12-4 , 550-70-9 , 6138-79-0 , 6138-79-0, 550-70-9 , 6138-79-0, 550-70-9 [anhydrous], 486-12-4 [triprolidine] , [550-70-9]
(E)-2-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)pyridine
(E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ium-1-ylprop-1-enyl]pyridine chloride
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride
486-12-4; D08648; Triprolidine (INN)
550-70-9; Prestwick_575; Triprolidine hydrochloride
6138-79-0 (mono-hydrochloride, mono-hydrate)
INN); Triprolidine Hydrochloride (FDA
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1)
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride
Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, (E)-
Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride, (E)-
Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, (E)-
Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, (E)-
Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, monohydrate, stereoisomer
trans-1-(2-Pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene
trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene
trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine
trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride
Triprolidine Hydrochloride (anhydrous)
Triprolidine hydrochloride anhydrous
Triprolidine Monohydrochloride
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.47 | 11.37 | -38.89 | 1 | 2 | 1 | 17 | 279.407 | 4 | ↓ |
Hi High (pH 8-9.5) | 3.47 | 8.91 | -5.89 | 0 | 2 | 0 | 16 | 278.399 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 5.37e-02 g/l | DrugBank-approved |
therap | antihistaminic | MicroSource Spectrum |
PUBCHEM_PATENT_ID | EP0842175A1; US5753671; US5866588 | IBM Patent Data |
Therapy | Potent H1 histamine receptor antagonist | SMDC MicroSource |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HRH1-2-E | Histamine H1 Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2 | 0.58 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 2512 | 0.37 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 1.6 | 0.59 | Binding ≤ 1μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 1.6 | 0.59 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 2511.88643 | 0.37 | Functional ≤ 10μM |
Description | Species |
---|---|
G alpha (q) signalling events | |
Histamine receptors |